Tumor necrosis factor-alpha augments matrix metalloproteinase-9 production in skeletal muscle cells through the activation of transforming growth factor-beta-activated kinase 1 (TAK1)-dependent signaling pathway
about
Tumor necrosis factor-α regulates distinct molecular pathways and gene networks in cultured skeletal muscle cellsGenomic profiling of messenger RNAs and microRNAs reveals potential mechanisms of TWEAK-induced skeletal muscle wasting in miceTransforming growth factor-beta-activated kinase 1 is an essential regulator of myogenic differentiation.Dissecting the role of AMP-activated protein kinase in human diseases.The TWEAK-Fn14 dyad is involved in age-associated pathological changes in skeletal muscleTranscriptional regulation of matrix metalloproteinase-1 and collagen 1A2 explains the anti-fibrotic effect exerted by proteasome inhibition in human dermal fibroblasts.Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice.Protein tyrosine phosphatase controls breast cancer invasion through the expression of matrix metalloproteinase-9Sulforaphane controls TPA-induced MMP-9 expression through the NF-κB signaling pathway, but not AP-1, in MCF-7 breast cancer cells.Saussurea lappa extract suppresses TPA-induced cell invasion via inhibition of NF-κB-dependent MMP-9 expression in MCF-7 breast cancer cells.Nuclear factor-kappa B signaling in skeletal muscle atrophy.Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx micePPARα and PPARγ protect against HIV-1-induced MMP-9 overexpression via caveolae-associated ERK and Akt signaling.The TWEAK-Fn14 system: breaking the silence of cytokine-induced skeletal muscle wasting.TNF-like weak inducer of apoptosis (TWEAK) activates proinflammatory signaling pathways and gene expression through the activation of TGF-beta-activated kinase 1Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy.Association between -308 G/A TNF-α polymorphism and appendicular skeletal muscle mass index as a marker of sarcopenia in normal weight obese syndromeTAK1 mRNA expression in the tumor tissue of locally advanced head and neck cancer patients.TWEAK/Fn14 Axis: A Promising Target for the Treatment of Cardiovascular Diseases.TWEAK/Fn14 Signaling Axis Mediates Skeletal Muscle Atrophy and Metabolic Dysfunction.Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations.Distinct roles of TRAF6 at early and late stages of muscle pathology in the mdx model of Duchenne muscular dystrophy.DHA blocks TPA-induced cell invasion by inhibiting MMP-9 expression via suppression of the PPAR-γ/NF-κB pathway in MCF-7 cells.Therapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophy.Doxycycline Inhibits IL-17-Stimulated MMP-9 Expression by Downregulating ERK1/2 Activation: Implications in Myogenic DifferentiationSesamin inhibits macrophage-induced vascular endothelial growth factor and matrix metalloproteinase-9 expression and proangiogenic activity in breast cancer cells.Suppression of LPS-induced matrix-metalloproteinase responses in macrophages exposed to phenytoin and its metabolite, 5-(p-hydroxyphenyl-), 5-phenylhydantoin.Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase: a potential rTAK-1/p38/nNFκB signaling inhibits myoblast differentiation by increasing levels of Activin A.Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-kappaB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes.Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells.The relationship between maximal exercise-induced increases in serum IL-6, MPO and MMP-9 concentrations.β2-Adrenoceptor is involved in connective tissue remodeling in regenerating muscles by decreasing the activity of MMP-9.
P2860
Q28475735-B3A4BC01-EE4F-4C03-AE35-FEC9E27C9670Q33526358-259B17A1-AE04-4DCC-8BC1-C8BFE148E504Q33673668-7A3AC065-F448-4C6F-888C-F916FC1486E5Q33682914-081450AB-832E-42F8-B9F1-81089324AD59Q33724956-F528052B-ECBD-4241-9FF2-727962FD34CAQ33923496-C7998261-F919-44C0-9FD8-5F294C489CEDQ33947243-9E489E65-0FFD-47E2-9443-053C0B0AE43DQ34049288-B4E30619-A9E0-413C-8FB9-20AB76644A80Q34049460-DAB5A781-B09D-4ED4-B0AA-C251C822C601Q34501113-954F85B7-94A1-451C-A179-033C6A3F74E6Q34593476-21522438-892E-46A1-BB54-6F282E335C91Q34973330-AF97A5A6-118F-456B-9F42-B72A84386F74Q35497152-50F0616F-E4A1-48C1-AD28-A085A8B2821EQ35671234-72F64560-3105-4C78-AA5F-2D1FE9A7DADBQ37119296-29ACDD07-A4E7-4D66-AEC0-5207DAC87A3CQ37239871-F8BB8587-2926-4B9E-AF9F-DE8855F3821BQ37316151-61F9A2D4-1FFD-45D2-AEB8-A8E962971C39Q37321864-33075D1E-9F0A-4843-9E91-E404012E565AQ37494039-9360F4E4-1378-43C7-AD11-3140F08036AAQ37516544-4A292F58-AC05-427D-8516-E11CA5F1297DQ37531997-926F9265-6C31-4CF0-A976-5706C4EC70D1Q37593034-BD96CD9F-4998-486E-888B-EDA9BAF89E27Q37594250-3C433D6C-F61A-4389-BD18-0CED02F0A0CEQ38264461-47D15C6B-0CC9-4159-87DF-911162EF494EQ38723327-41365D89-452E-42AB-AEC6-3FDD3F452B46Q39682412-D33C5FC0-ECFA-4841-9F96-61848DD3BED2Q41761895-2724A33E-242F-4D72-B11F-F2380C8F6FF4Q42058317-C1F91069-06AB-40C3-BAD2-EC58941EE2C9Q42117099-0A8FA599-B12D-4993-9C7D-BD9947A23D70Q42803133-4F1B14DF-0B95-4E1D-985C-CC33A379CE15Q46483152-57441C4B-6AD7-4694-A907-4FD55F4F63C8Q49179617-02DAD6BE-A0CD-417F-82DB-92C4ECD7CD59Q50532122-DA29CEB8-66C9-413E-A592-6622EC160661
P2860
Tumor necrosis factor-alpha augments matrix metalloproteinase-9 production in skeletal muscle cells through the activation of transforming growth factor-beta-activated kinase 1 (TAK1)-dependent signaling pathway
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Tumor necrosis factor-alpha au ...... 1)-dependent signaling pathway
@ast
Tumor necrosis factor-alpha au ...... 1)-dependent signaling pathway
@en
Tumor necrosis factor-alpha au ...... factor-beta-activated kinase 1
@nl
type
label
Tumor necrosis factor-alpha au ...... 1)-dependent signaling pathway
@ast
Tumor necrosis factor-alpha au ...... 1)-dependent signaling pathway
@en
Tumor necrosis factor-alpha au ...... factor-beta-activated kinase 1
@nl
prefLabel
Tumor necrosis factor-alpha au ...... 1)-dependent signaling pathway
@ast
Tumor necrosis factor-alpha au ...... 1)-dependent signaling pathway
@en
Tumor necrosis factor-alpha au ...... factor-beta-activated kinase 1
@nl
P2093
P2860
P356
P1476
Tumor necrosis factor-alpha au ...... 1)-dependent signaling pathway
@en
P2093
Apurva K Srivastava
Marc Arnush
Nia Wedhas
Robert B Chadwick
Thomas A Linkhart
Xuezhong Qin
P2860
P304
35113-35124
P356
10.1074/JBC.M705329200
P407
P50
P577
2007-09-26T00:00:00Z